Inflammatory Bowel Disease
Show Only Open Trials
1.
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
- Study Status: Open to Enrollment
- Sponsor: Elan Pharmaceuticals
- Disease Status and/or Stage: Crohn's Disease Being Treated with TYSABRI
2.
The Multi-Center African American IBD Study (MAAIS)
- Study Status: Open to Enrollment
- Sponsor: National Institutes of Digestive Diseases and Kidney (NIDDK)
- Disease Status and/or Stage: African-Americans with IBD, a Family Member with IBD, or Healthy Volunteers
